Clinical Usefulness and Quality of Life of OROS Hydromorphone in Patients Who Have Not Been Treated With a Strong Opioid
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the usefulness of hydromorphone to treat
cancer pain in patients who have not been treated with a strong opioid.